GEN Exclusives

More »

GEN News Highlights

More »
May 21, 2007

Evotec Launches Innovation Centre for Fragment-Based Drug Discovery

  • Evotec launched the Innovation Centre for Fragment Based Drug Discovery (FBDD) that will offer an alternative approach for identifying novel, small molecule hits for a number of biological targets.

    The company has established a scientific board for this Innovation Centre to advise on the selection of high-quality biological targets for Evotec's pipeline of projects for partnering. The board will also advise on the development of these programs and identify areas to further enhance the technology base.

    Fragments are difficult to detect due to their weak interactions with protein target, Evotec explains. The company thus implemented a unique fragment screening platform, EVOlution, capable of identifying low molecular weight fragments in a biologically relevant environment.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?